The stock of Vernalis plc (LON:VER) is a huge mover today! The stock decreased 5.13% or GBX 1.74 on November 23, hitting GBX 32.26. About 630,547 shares traded hands or 110.50% up from the average. Vernalis plc (LON:VER) has declined 32.00% since April 25, 2016 and is downtrending. It has underperformed by 37.33% the S&P500.
The move comes after 6 months negative chart setup for the GBX 169.78M company. It was reported on Nov, 23 by Barchart.com. We have GBX 30.97 PT which if reached, will make LON:VER worth GBX 6.79M less.
Vernalis plc (LON:VER) Ratings Coverage
Out of 5 analysts covering Vernalis PLC (LON:VER), 4 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 80% are positive. GBX 138 is the highest target while GBX 46 is the lowest. The GBX 77.67 average target is 140.76% above today’s (GBX 32.26) stock price. Vernalis PLC has been the topic of 31 analyst reports since August 20, 2015 according to StockzIntelligence Inc. Stifel Nicolaus maintained the shares of VER in a report on Friday, July 8 with “Buy” rating. The company was maintained on Thursday, September 29 by N+1 Singer. The firm earned “Buy” rating on Friday, May 20 by Canaccord Genuity. Cantor Fitzgerald maintained the stock with “Buy” rating in Wednesday, April 13 report. The stock has “Buy” rating given by N+1 Singer on Monday, October 12. The firm earned “Buy” rating on Thursday, August 20 by N+1 Singer. N+1 Singer maintained Vernalis plc (LON:VER) on Monday, December 21 with “Buy” rating. The rating was maintained by Canaccord Genuity on Tuesday, September 29 with “Buy”. On Friday, July 8 the stock rating was maintained by Cantor Fitzgerald with “Buy”. Panmure Gordon maintained the shares of VER in a report on Thursday, September 22 with “Buy” rating.
More recent Vernalis plc (LON:VER) news were published by: Uk.Finance.Yahoo.com which released: “-LSE Ticker: 3Y5L75/ISIN: GB00B3Y5L754” on March 29, 2014. Also Fool.Co.Uk published the news titled: “Is Vernalis plc The Perfect Partner For BTG plc In Your Portfolio?” on May 01, 2015. Fool.Co.Uk‘s news article titled: “Is Vernalis plc The Perfect Partner For GlaxoSmithKline plc In Your Portfolio?” with publication date: September 15, 2014 was also an interesting one.
Vernalis plc is a commercial-stage pharmaceutical company. The company has a market cap of 169.78 million GBP. The Firm is engaged in the research, development and commercialization of pharmaceutical products. It currently has negative earnings. The Firm operates through two divisions: Commercial, which covers all areas relating to the commercial sale of pharmaceutical products, the manufacture and distribution directly related to that activity, and Research and Development, which includes all activities related to the research and development of pharmaceutical products for a range of medical disorders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.